↓ Skip to main content

Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia

Overview of attention for article published in Cochrane database of systematic reviews, January 2007
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
3 news outlets
twitter
2 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
173 Dimensions

Readers on

mendeley
180 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia
Published in
Cochrane database of systematic reviews, January 2007
DOI 10.1002/14651858.cd004597.pub2
Pubmed ID
Authors

Ann Dewey, Chris Baughan, Taraneh P Dean, Bernie Higgins, Ian Johnson

Abstract

Cancer cachexia is a distressing weight loss syndrome commonly seen in advanced cancer patients. It is associated with reduced quality of life and shorter survival time. Eicosapentaenoic acid (EPA) is a long chain polyunsaturated fatty acid found naturally in some fish which has been used to decrease weight loss, promote weight gain and increase survival times in patients affected with cancer cachexia.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 180 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 3 2%
South Africa 1 <1%
Hong Kong 1 <1%
Australia 1 <1%
Italy 1 <1%
India 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
France 1 <1%
Other 0 0%
Unknown 169 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 16%
Researcher 28 16%
Student > Bachelor 27 15%
Student > Ph. D. Student 21 12%
Student > Postgraduate 12 7%
Other 41 23%
Unknown 22 12%
Readers by discipline Count As %
Medicine and Dentistry 80 44%
Agricultural and Biological Sciences 20 11%
Nursing and Health Professions 14 8%
Biochemistry, Genetics and Molecular Biology 8 4%
Social Sciences 6 3%
Other 19 11%
Unknown 33 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2016.
All research outputs
#622,773
of 13,604,426 outputs
Outputs from Cochrane database of systematic reviews
#1,977
of 10,674 outputs
Outputs of similar age
#14,755
of 298,999 outputs
Outputs of similar age from Cochrane database of systematic reviews
#61
of 249 outputs
Altmetric has tracked 13,604,426 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,674 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 298,999 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 249 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.